Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julian R de Ruiter

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Nucleic Acids Research|June 3, 2017
Identifying transposon insertions and their effects from RNA-sequencing dataJulian R de Ruiter, Sjors M Kas, Eva Schut, et al.
Cell Reports|August 16, 2016
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular CarcinomaMirjam C Boelens, Micha Nethe, Sjoerd Klarenbeek, et al.
Nature Methods|December 20, 2017
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistanceAlexandra A Duarte, Ewa Gogola, Norman Sachs, et al.
Cancer Research|August 18, 2018
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547Sjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
BMC Bioinformatics|October 6, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataRoelof J C Kluin, Kristel Kemper, Thomas Kuilman, et al.
Nature Genetics|June 27, 2017
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinomaSjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
Nature Communications|January 25, 2019
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancerStefano Annunziato, Julian R de Ruiter, Linda Henneman, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
Nature|July 23, 2016
Replication fork stability confers chemoresistance in BRCA-deficient cellsArnab Ray Chaudhuri, Elsa Callen, Xia Ding, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Nucleic Acids Research|June 3, 2017
Identifying transposon insertions and their effects from RNA-sequencing dataJulian R de Ruiter, Sjors M Kas, Eva Schut, et al.
Cell Reports|August 16, 2016
PTEN Loss in E-Cadherin-Deficient Mouse Mammary Epithelial Cells Rescues Apoptosis and Results in Development of Classical Invasive Lobular CarcinomaMirjam C Boelens, Micha Nethe, Sjoerd Klarenbeek, et al.
Nature Methods|December 20, 2017
BRCA-deficient mouse mammary tumor organoids to study cancer-drug resistanceAlexandra A Duarte, Ewa Gogola, Norman Sachs, et al.
Cancer Research|August 18, 2018
Transcriptomics and Transposon Mutagenesis Identify Multiple Mechanisms of Resistance to the FGFR Inhibitor AZD4547Sjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
BMC Bioinformatics|October 6, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence dataRoelof J C Kluin, Kristel Kemper, Thomas Kuilman, et al.
Nature Genetics|June 27, 2017
Insertional mutagenesis identifies drivers of a novel oncogenic pathway in invasive lobular breast carcinomaSjors M Kas, Julian R de Ruiter, Koen Schipper, et al.
Nature Communications|January 25, 2019
Comparative oncogenomics identifies combinations of driver genes and drug targets in BRCA1-mutated breast cancerStefano Annunziato, Julian R de Ruiter, Linda Henneman, et al.
Cell Reports|May 20, 2023
Multi-omics analysis reveals distinct non-reversion mechanisms of PARPi resistance in BRCA1- versus BRCA2-deficient mammary tumorsJinhyuk Bhin, Mariana Paes Dias, Ewa Gogola, et al.
Nature|July 23, 2016
Replication fork stability confers chemoresistance in BRCA-deficient cellsArnab Ray Chaudhuri, Elsa Callen, Xia Ding, et al.
Cancer Cell|June 13, 2018
Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic LethalityEwa Gogola, Alexandra A Duarte, Julian R de Ruiter, et al.
Pageof 2